X-ray crystal structure of 28-o-methylrapamycin complexed with fkbp12: is the cyclohexyl moiety part of the effector domain of rapamycin? Deposition Author(s): Kallen, J.
Date: 2012-01-27 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Homo Sapiens Sequences Data: 4DH0_A
The central valine concept provides an entry in a new class of non peptide inhibitors of the p53-mdm2 interaction Deposition Author(s): Kallen, J.
Date: 2012-01-31 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Homo Sapiens Sequences Data: 4DIJ_A , 4DIJ_B
X-ray structure of lfa-1 i-domain in complex with ibe-667 at 1.8a resolution Deposition Author(s): Kallen, J.
Date: 2013-01-25 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Homo Sapiens Sequences Data: 4IXD_A
Tetra-substituted imidazoles as a new class of inhibitors of the p53-mdm2 interaction Deposition Author(s): Kallen, J.
Date: 2014-02-07 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Homo Sapiens Sequences Data: 4OQ3_A , 4OQ3_B , 4OQ3_C , 4OQ3_D
Discovery of dihydroisoquinolinone derivatives as novel inhibitors of the p53-mdm2 interaction with a distinct binding mode: hdm2 (mdm2) complexed with cpd5 Deposition Author(s): Kallen, J.
Date: 2015-05-21 Method: X-RAY DIFFRACTION Resolution: 1.95 Å Organism(s): Homo Sapiens Sequences Data: 4ZYC_A , 4ZYC_B , 4ZYC_C
Discovery of nvp-cgm097 - a highly potent and selective mdm2 inhibitor undergoing phase 1 clinical trials in p53wt tumors: hdm2 (mdm2) complexed with nvp-cgm097 Deposition Author(s): Kallen, J.
Date: 2015-05-21 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Homo Sapiens Sequences Data: 4ZYF_A
Discovery of nvp-cgm097 - a highly potent and selective mdm2 inhibitor undergoing phase 1 clinical trials in p53wt tumors: hdm2 (mdm2) complexed with cpd2 Deposition Author(s): Kallen, J.
Date: 2015-05-21 Method: X-RAY DIFFRACTION Resolution: 1.67 Å Organism(s): Homo Sapiens Sequences Data: 4ZYI_A
Discovery of a novel class of highly potent inhibitors of the p53-mdm2 interaction by structure-based design starting from a conformational argument Deposition Author(s): Kallen, J.
Date: 2016-08-02 Method: X-RAY DIFFRACTION Resolution: 1.58 Å Organism(s): Homo Sapiens Sequences Data: 5LN2_A
Synthesis and biological evaluation of new triazolo and imidazolopyridine rorgt inverse agonists Deposition Author(s): Kallen, J.
Date: 2016-10-31 Method: X-RAY DIFFRACTION Resolution: 1.77 Å Organism(s): Homo Sapiens Sequences Data: 5M96_A , 5M96_B
Structural states of rorgt: x-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds Deposition Author(s): Kallen, J.
Date: 2017-04-28 Method: X-RAY DIFFRACTION Resolution: 2.4 Å Organism(s): Homo Sapiens Sequences Data: 5NTI_A , 5NTI_B , 5NTI_C , 5NTI_D , 5NTI_P , 5NTI_Q , 5NTI_R , 5NTI_S